A reduced dose of elective radiation is safe and does not compromise treatment efficacy in patients with head and neck ...

These scientists sought to answer a simple question. They ended up stumbling upon a discovery that could pave the way for a ...

Ravindra Uppaluri, MD, PhD, discussed the KEYNOTE-689 trial, which investigated pembrolizumab in locally advanced head and ...

When Jamie Powell was told she would have to have part of her tongue removed, she was determined to do something for her kids ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Katherine Ryan has asked health experts 'am I going to die' after they told her 'no good news' while discussing her real ...

The addition of neoadjuvant and adjuvant pembrolizumab to standard of care significantly improved outcomes for certain ...

The comedian, 41, recently revealed she was left thinking she was going to die after being told she has medical age of 77 ...

Ravindra Uppaluri, MD, PhD, lead investigator of the phase 3 KEYNOTE-689 trial (NCT03765918), highlights the potential of pembrolizumab (Keytruda; Merck) to improve outcomes following head and neck ...

After further evaluation, she was diagnosed with cholangiocarcinoma, or bile duct cancer, a rare and aggressive cancer that ...